Pharmacology of trace amine-induced vasodilatation: roles of endothelium
and intracellular sites
Abstract
Abstract Background and Purposes: Although trace amines, including
β-phenylethylamine (β-PEA), cause vasoconstriction, they also induce
endothelial nitric oxide release via an unknown mechanism. This study
evaluates the cellular site of action and receptors mediating
β-PEA-induced vasodilation. Experimental Approach: In vitro vasodilator
responses to β-PEA were assessed using aortic rings and third-order
mesenteric arteries of male Sprague-Dawley rats. Key Results:
β-PEA-induced concentration-dependent vasodilation of pre-constricted
aortic rings and third-order mesenteric arteries were partially
sensitive and insensitive to endothelium removal, respectively. In
aortic rings vasodilator responses to β-PEA were unaffected by EPPTB, a
selective antagonist of murine trace amine associated receptor 1
(TAAR1), or antagonists of β2-adrenoceptors and muscarinic acetylcholine
M3 receptors. The inhibitor of uptake-2 transport, decynium-22,
abolished β-PEA-induced vasodilation revealing a vasoconstrictor
response. Conclusion and Implications: Vasodilator responses to β-PEA do
not involve cell surface receptors. We propose that β-PEA utilises
uptake-2 transporters to gain access to an intracellular site. Although
the identify of the intracellular site is unknown, the mechanism is
similar to that previously reported where intracellular TAAR1 medated
responses in HEK293 cells. Vasodilatation is the dominant response to
trace amines of mesenteric vessels whereas in the aorta, it opposes
vasoconstriction.